
Eris Lifesciences
NSE: ERIS | BSE: 540596
₹1,507.00
+₹13.50 (0.90%) TodayLast updated on 05 May, 2025 | 15:49 ISTMarket cap | Open ₹1,518.00 | Prev. Close ₹1,493.50 |
Circuit range ₹1,792.20 - ₹1,194.80 | Day range ₹1,480.10 - ₹1,519.70 | Year range ₹815.85 - ₹1,593.90 |
Volume 2,51,347 | Avg. traded ₹1,510.97 | Revenue (12m) ₹2,739 Crs |
About Eris Lifesciences
Eris Lifesciences Limited is an India-based pharmaceutical company. The Company is engaged in the manufacture and marketing of pharmaceutical products. The Company has a presence in major therapies like oral anti-diabetes, insulins, cardiovascular, vitamins/minerals and dermatology. Its flagship therapies include oral anti-diabetes, cardiovascular disease (CVD), and vitamins, minerals and nutrients (VMN). Its emerging therapies consist of dermatology, insulins, women’s health, central nervous system (CNS), oncology, and nephrology. Its portfolio of brands includes Glimisave, Eritel, LNBloc, Olmin, Crevast, Atorsave, Gluxit, Renerve, Zomelis, Cosvate, Tayo, Cyblex, Remylin, Tendia, Rabonik, Ginkocer, Psorid, Raricap, Serlift, and Onabet, among others. Its patient care initiatives (PCI) platform provides various healthcare solutions to its patients. The Company has a manufacturing plant located in Guwahati, Assam.
Eris Lifesciences Share Price Chart
Please wait...
Eris Lifesciences Fundamentals
Eris Lifesciences Key indicators
52 week high ₹1,593.90 | 52 week low ₹815.85 | P/E ratio 61.78 |
P/B ratio 7.08 | ROE 12.65% | ROCE 10.17% |
Dividend yield -- | Debt/Equity ratio 1 | EPS 22.03 |
Featured in
Investment checklist: (4/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst ratings:
88%
Hold
12%
Sell
0%
This analysis is based on the reviews of 8 experts in the last 7 days
Eris Lifesciences Financial Ratios
Operating profit margin31.28% | Net profit margin19.19% |
ROE12.65% | ROA7.79% |
ROCE10.17% |
Quick ratio0.79 | Current ratio0.83 |
Interest coverage6.73 | Asset turnover0.41 |
Debt to Equity1 |
P/E ratio61.78 | P/B ratio7.08 |
EV / EBITDA25.94 | |
Dividend yield0% |
Revenue statement
All values are in ₹ Crores (Cr)

Loading chart data
Cash flow
All values are in ₹ Crores (Cr)

Loading chart data
Balance sheet
All values are in ₹ Crores (Cr)

No data available at the moment
Total assets
Total liabilities
Eris Lifesciences Share Price history
Day | Open | Close | Change % |
---|---|---|---|
Fri, May 2 2025 | ₹1,440.10 | ₹1,493.50 | |
Wed, Apr 30 2025 | ₹1,454.50 | ₹1,432.10 | -2.23% |
Tue, Apr 29 2025 | ₹1,500.00 | ₹1,464.80 | -1.45% |
Mon, Apr 28 2025 | ₹1,468.20 | ₹1,486.30 | |
Fri, Apr 25 2025 | ₹1,512.00 | ₹1,468.20 | -2.90% |
Thu, Apr 24 2025 | ₹1,490.00 | ₹1,512.00 | |
Wed, Apr 23 2025 | ₹1,415.00 | ₹1,474.20 | |
Tue, Apr 22 2025 | ₹1,370.00 | ₹1,399.40 |
Events
Corporate actions
Dividend • ₹7.35/share
Ex date 13 Feb 2025
More
Stocks Similar to Eris Lifesciences
Popular Stocks
Eris Lifesciences News
FAQs on Eris Lifesciences
What is the Eris Lifesciences share price today?
Eris Lifesciences share price is ₹ 1,507.00 as on 05 May, 2025 | 19:37 IST
What is today’s high & low share price of Eris Lifesciences?
Eris Lifesciences share price high: ₹ 1,519.70 and low: ₹ 1,480.10 as on 05 May, 2025 | 19:37 IST
What is the Eris Lifesciences share price high and low in the last 52 weeks on the NSE?
52 Week share High Price is ₹ 1,593.90 and Low Price is ₹ 815.85 as on 05 May, 2025 | 19:37 IST
What is the Eris Lifesciences Stock Symbol?
The Eris Lifesciences Stock symbol is ERIS.
Can I buy Eris Lifesciences shares on Holidays?
No, shares of Eris Lifesciences or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Eris Lifesciences shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.